watch
Synergy Pharmaceuticals, Inc.

Synergy Pharmaceuticals, Inc.

Sector: Pharmaceutical Preparations Region: NY, United States


: | Nasdaq: SGYP | Nasdaq: SGYPW | Nasdaq: SGYPU


Similar to: Bohai Pharmaceuticals Group, Inc., Ipsen SA, Pernix Therapeutics Holdings, Inc.

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its proprietary drug candidate Plecanatide is a synthetic analog of the human gastrointestinal hormone uroguanylin, and functions by activating the Guanylate Cyclase C receptor on epithelial cells of the GI tract. The company was founded on November 15, 2005 and is headquartered in New York, NY.

News & Analysis

You may also be interested in: